Press

Stephen G. Sudovar Reelected to the Nabi Biopharmaceuticals’ Board of Directors

Montclair, New Jersey, August 10th, 2009 — SGS Associates Inc., a Business Consulting Firm focusing on clients within both Pharmaceutical and Biopharmaceutical Companies, announced today that Stephen Sudovar, the Company’s Chairman and CEO, has been reelected to the Board of Directors of Nabi Biopharmaceuticals Inc. (NASDAQ: NABI).

Mr. Sudovar has been a member of the Nabi Board since May, 2002. Nabi develops products that target serious medical conditions in the areas of nicotine addiction and gram-positive bacterial infections. The company, which is located in Rockville, Maryland, is currently developing  NicVAX (Nicotine Conjugate Vaccine), a vaccine for the treatment of nicotine addiction and smoking relapse, and PentaStaph (Pentavalent S. aureus Vaccine), a vaccine designed to prevent the most dangerous and prevalent strains of S. aureus bacterial infections. 

"I am honored to continue serving as an Independent Director at Nabi representing the many shareholders of the company. I also look forward to continuing to work with my very accomplished fellow board members and the Nabi senior management team. I am particularly excited about our late stage product, NicVax, which I believe holds the promise of making a great contribution to the health and well being of patients around the world who suffer with nicotine addiction."

Prior to being the founder of SGS Associates, Mr. Sudovar was CEO of Elusys Therapeutics Inc., President of Roche Laboratories Inc. and President and CEO of Pracon Incorporated. During his over thirty years of senior management experience, Mr. Sudovar has been in leadership positions in both a large global Pharmaceutical Company (Roche) as well as smaller entrepreneurial development stage companies. He was the founder of Pracon Incorporate and was the first CEO of Elusys Therapeutics Inc.

In addition to his vast private sector Health Care Industry experience, Mr. Sudovar has worked in both Government and Academia. Early in his career, Mr. Sudovar was appointed by the President of the United States to serve as a Deputy to the Assistant Administrator of Planning Evaluation and Legislation at the Environmental Protection Agency. Currently, in addition to his work at SGS Associates, Mr. Sudovar is an Adjunct Professor of Management at Montclair State University (MSU). He has been teaching Strategic Management at MSU for the last eight semesters.

Mr. Sudovar holds a B.S. in Marketing from St. Peter’s College and an M.B.A. from Fairleigh Dickenson University. Mr. Sudovar is also on the Board of Aastrom Biosciences Inc.

About SGS Associates Inc.

SGS Associates is a management consulting firm serving Pharmaceutical and Biopharmaceutical industry clients. Areas of concentration for SGS Associates are corporate governance, business assessment and strategy formulation and government affairs.

In Mr. Sudovar’s Consulting Practice he offers his services as a Board Member, Hands-on Short-term General Manager (CEO/COO/CFO), Investor and M&A Consultant and Senior Management Advisor. His focus has been on small to medium size Biotechnology and Pharmaceutical firms.

For more information about SGS Associates please go to www.sgsassociates.com.

 

 

view all press releases

 

Experience

Executive Overview

Thirty years of extraordinary accomplishments in driving business growth in the healthcare products and services industry.

view resumePDF icon

Capabilities

  • Board of Directors
  • General Management
  • Strategic Planning
  • Business Development
  • Mergers and Acquisitions
  • Government Affairs view all
louis vuitton outlet thunder 14s thunder 14s Michael Kors Outlet louis vuitton outlet jordan 3 sport blue sport blue 3s coach factory outlet online thunder 14s thunder 14s louis vuitton outlet michael kors outlet louis vuitton outlet sport blue 6s michael kors outlet jordan 3 sport blue wolf grey 3s jordan 3 sport blue louis vuitton outlet michael kors outlet